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Mononucleosomes, the basic building blocks of
chromatin, contain two copies of each core histone.
The associated posttranslational modifications regu-
late essential chromatin-dependent processes, yet
whether each histone copy is identically modified
in vivo is unclear. We demonstrate that nucleosomes
in embryonic stem cells, fibroblasts, and cancer cells
exist in both symmetrically and asymmetrically
modified populations for histone H3 lysine 27 di/
trimethylation (H3K27me2/3) and H4K20me1. Fur-
ther, we obtained direct physical evidence for biva-
lent nucleosomes carrying H3K4me3 or H3K36me3
along with H3K27me3, albeit on opposite H3 tails.
Bivalency at target genes was resolved upon differ-
entiation of ES cells. Polycomb repressive complex
2-mediated methylation of H3K27 was inhibited
when nucleosomes contain symmetrically, but not
asymmetrically, placed H3K4me3 or H3K36me3.
These findings uncover a potential mechanism for
the incorporation of bivalent features into nucleo-
somes and demonstrate how asymmetry might set
the stage to diversify functional nucleosome states.
INTRODUCTION
The nucleosome represents the smallest unit of chromatin struc-
ture, consisting of 147 bp of DNA wrapped around a histone
octamer that contains two copies each of the core histones
H2A, H2B, H3, and H4 (Luger et al., 1997). Histones are subject
to a variety of posttranslational modifications (PTMs) (Bannister
and Kouzarides, 2011). These modifications have been shown
to act as key regulators of gene expression, DNA repair, and
manyother essential chromatin-associatedprocessesbydirectly
modulating chromatin structure and recruiting effector proteins
that harbor PTM-specific binding domains (Bannister and Kou-
zarides, 2011; Campos andReinberg, 2009; Taverna et al., 2007).
Histone PTMs rarely function in isolation but act in the context
of other histone marks, other histones within the nucleosome,and neighboring nucleosomes. A range of effector proteins
have been described that contain multiple binding domains for
the same or different histone modifications (Ruthenburg et al.,
2007). Moreover, effector proteins often form multimeric com-
plexes that bring together different binding modules, as
described, e.g., for the TFIID complex (Vermeulen et al., 2007).
Such multivalency can also be achieved through homomultime-
rization of histone-binding proteins. In these cases, recognition
of multiple binding determinants thermodynamically enhances
binding affinity and also specificity (Voigt and Reinberg, 2011).
In light of these observations, it is critical to establish which
combinations of histone marks occur within the same nucleo-
some in vivo and whether a mark is present on both histone
copies per nucleosome or only one.
A wealth of information regarding the genomic localization of
histone PTMs has been derived from genome-wide chromatin
immunoprecipitation (ChIP) studies, which also point to many
correlations betweenmodifications (Wang et al., 2008). A special
case is the so-called ‘‘bivalent domain’’ that contains histone H3
lysine 4 trimethylation (H3K4me3), a mark associated with active
transcription, along with the repressive mark H3K27me3. Such
bivalent domains are found at developmentally regulated gene
promoters, predominantly in embryonic stem (ES) cells but
also in other cell types (Bernstein et al., 2006; Fisher and Fisher,
2011; Mikkelsen et al., 2007). Both the nucleosomal conforma-
tion of these bivalent sites as well as the mechanism for their
establishment have yet to be resolved. Whereas ChIP studies
are highly informative regarding the genomic localization
and the correlation of different marks, they usually cannot
establish physical coexistence of marks on the same nucleo-
some nor discriminate between the tails of sister histones within
a nucleosome.
Based on multiple lines of evidence, histone marks have been
proposed to carry epigenetic information, and several theories
have been put forward as to how histone modification patterns
might be faithfully transmitted to daughter cells upon cell division
(Kaufman and Rando, 2010; Margueron and Reinberg, 2010;
Probst et al., 2009). These models postulate that parental
histones act as templates for histone-modifying enzymes in
restoring the original modification patterns to newly replicated
chromatin in a faithful manner. Lysine methylation and acetyla-
tion on H3 and H4 are the major candidates for epigeneticCell 151, 181–193, September 28, 2012 ª2012 Elsevier Inc. 181
Figure 1. Analysis of Histone Modification
Symmetry by Immunoaffinity Purification
and Mass Spectrometry
(A) Outline of the experimental approach. See
main text for details.
(B) For a hypothetical binary (unmodified/
modified) mark, asymmetric nucleosomes give
rise to equal amounts of modified and unmodified
peptide, whereas the symmetric case yields only
the modified peptide.
(C) If a mixed population is present, the abun-
dance of unmodified peptide decreases with in-
creasing proportions of symmetric nucleosomes.
The peptide quantification yields the relative
amount of symmetric and asymmetric pop-
ulations through interpolation between the limiting
cases.
(D) Modifications covered in MS analysis. Tryptic
peptides generated from propionylated histones
H3 and H4 are shown along with detected acet-
ylation and methylation sites.
See also Figure S1.histone marks. The H3-H4 tetramer can be segregated as
a tetramer, randomly deposited onto the two daughter strands,
or as two H3-H4 dimers, generated by the histone chaperone
Asf1 (Ransom et al., 2010), which would allow inheritance of
marks in a semiconservative fashion. Although most studies
argue against a splitting model, the question remains contested,
and mechanisms of inheritance are largely unresolved at
present. Several theories for histonemark inheritance, especially
the semiconservative model involving redeposition of parental
H3-H4 dimers, require histones to carry identical modifications
on both copies within a nucleosome (Margueron and Reinberg,
2010; Probst et al., 2009).
Given the apparent symmetry of the nucleosome, the two
copies of each core histone are commonly considered to be
interchangeable and identical. However, the validity of this
assumption has thus far evaded experimental scrutiny. The
symmetry state of a given histone modification within the nucle-
osome in vivo has remained elusive, rendering it a long-standing
question in chromatin biology. We set out to devise an approach
for the investigation of modification symmetry and demonstrate
that a significant proportion of nucleosomes are asymmetrically
modified in ES cells, mouse embryonic fibroblasts (MEFs), and182 Cell 151, 181–193, September 28, 2012 ª2012 Elsevier Inc.HeLa cells with respect to two prominent
histone modifications, H3K27me2/3 and
H4K20me1.
RESULTS
An Approach to Analyze Histone
Modification Symmetry
To analyze whether sister histones
in nucleosomes are symmetrically or
asymmetrically modified in vivo, we
devised a strategy that is based on
affinity purification of micrococcal nucle-
ase (MNase)-generated mononucleo-somes using modification-specific antibodies. Purification is
followed by liquid chromatography (LC)-coupled MS analysis
to quantify the abundance of histone modifications. MS-based
quantification is performed by chromatographic peak integra-
tion, with MS/MS data providing unambiguous assignment of
peptide identities and modification states (Plazas-Mayorca
et al., 2009). Advances in MS instrumentation have made such
approaches feasible, and work by several groups in recent years
has shown that histone modifications can be reliably quantified
in that way (see e.g., Garcia et al., 2007b; Peters et al., 2003;
Syka et al., 2004 for early examples). With respect to a single
modification, nucleosomes in chromatin can potentially exist in
one of three states: unmodified, modified on one, or both sister
histones (Figure 1A). Given specificity of an antibody for that
modification, immunoaffinity purification of mononucleosomes
exclusively yields nucleosomes that carry the modification on
at least one sister histone while eliminating unmodified nucleo-
somes. After derivatization and tryptic digest of histones, the
relative abundance of the modification is quantified for the anti-
body-selected nucleosomes by LC-coupled MS/MS analysis.
One of three outcomes is expected as follows. In the case of
a symmetric modification, all peptides containing the candidate
site would be detected as modified (Figure 1A, left). In the asym-
metric case, unmodified peptides would originate from sister
histones that are copurified with modified histones (Figure 1A,
right), such that the modified peptide comprises only 50% (Fig-
ure 1B). However, if the nucleosome population comprises
both symmetrical and asymmetrical versions, the modified
peptide would amount to between 50% and 100%, with its
abundance directly corresponding to the relative extent of
symmetric versions (Figure 1C). The peptides generated and
sites covered in our analysis are shown in Figure 1D.
To test our approach, we generated chemically modified
histones containing methyl-lysine analogs (MLAs) (Simon et al.,
2007) and assembled them into recombinant histone octamers
that contained the H3K27me3 mark either on one or both copies
of H3 with the help of epitope-tagged versions of H3 (see
Extended Experimental Procedures available online). As ex-
pected, in the symmetric case, only the trimethylated form of
the H3(27–40) peptide could be detected (Figure S1A), whereas
the asymmetric case yielded both the trimethylated and unmod-
ified peptide (Figure S1B) in close to equal abundance. We
further subjected mixtures of H3K27me3- and H4K20me1-
MLA-containing histone octamers to SDS-PAGE and subse-
quent sample preparation. We observed very good correlation
between expected and observed values over a wide range of
ratios (Figure S1C), confirming the well-established reliability of
LC-MS/MS-based relative quantification of histone modifica-
tions in our experimental setting.
To investigate histone modification symmetry in a range of
different cell types in vivo, we prepared mononucleosomes
from ES, MEFs, and HeLa cells by MNase digestion with two
independent preparations per cell type. Subsequent sucrose
gradient centrifugation (see Figure S1D for a representative frac-
tionation) yielded essentially pure preparations with on average
93.5% mononucleosomes, containing traces of dinucleosomes
(Figure S1E). For reference, the modification patterns of the
mononucleosome preparations were determined by LC-MS/
MS analysis (Table S1).
Nucleosomes Are Modified with H3K27me2/3 Both
Symmetrically and Asymmetrically
We first applied this methodology to probe for the symmetry of
the repressive modification H3K27me3, catalyzed by PRC2.
Trimethylation of H3K27 is a pivotal mark in the establishment
and maintenance of repressive chromatin states from early
development to adulthood (Margueron and Reinberg, 2011;
Simon and Kingston, 2009). A prerequisite for the success of
our approach is that the modification-directed antibodies must
be highly specific. We compared several H3K27me3-specific
antibodies by western blot using MLA histones. Only a single
antibody (in-house generated monoclonal 7B11) was rigorously
specific for the higher degrees of H3K27 methylation, detecting
only H3K27me2/3 while not cross-reacting with H3K9 methyla-
tion (Figure S2A). Of note, no material was immunopurified
from mononucleosomes prepared from Eed/ ES cells, which
are virtually devoid of H3K27me2/3, underscoring antibody
specificity (Figure 2A). To analyze modification symmetry, the
antibody should further exhibit comparable affinity for mononu-
cleosomes containing one or two H3K27me2/3 marks. Indeed,using recombinant, defined symmetric, or asymmetric mononu-
cleosomes in immunoprecipitations (IPs), the antibody was simi-
larly effective (Figure S2B). Moreover, detection of H3K27me2/3
was unaffected by the presence of other modifications such as
H3K4me3 or H3K36me3 on the same H3 tail (Figure S2C).
H3K27me2/3-modified mononucleosomes (from here on
referred to as H3K27me2/3 nucleosomes) were immunoprecipi-
tated with the 7B11 antibody (Figure 2A) and subjected to LC-
MS/MS analysis. Surprisingly, immunoprecipitated H3K27me2/
3 nucleosomes exhibited significant amounts of histones carry-
ing either unmodified or monomethylated H3K27 irrespective
of cell type (Figure 2B). These findings indicate that a significant
amount of mononucleosomes is asymmetrically modified in vivo.
For H3K27me2/3 nucleosomes in E14 ES cells, 79% ± 2% of
all H3 tails contain the H3K27me2/3 mark, whereas 21% ±
2% are either unmethylated or monomethylated, yielding
58% ± 3% of symmetric and 42% ± 3% asymmetric nucleo-
somes. Similar levels of asymmetry were observed for HeLa
cells, MEFs, and an additional ES cell line (Figure 2B). Taken
together, nucleosomes exhibit both symmetric and asymmetric
H3K27 modification in vivo.
H4K20me1 Also Exists Asymmetrically
To probe symmetry for another histone PTM, we analyzed
H4K20me1, which is established by PR-Set7 and participates
in chromosome condensation during mitosis, the DNA damage
response, and has been correlatedwith both actively transcribed
and repressed genes (Beck et al., 2012). A commercially avail-
able antibody proved to be specific for H4K20me1, as no
cross-reactivity was observed with other methylation sites, and
acetylation at H4K16 did not interfere with IP (Figures S2D and
S2F). Importantly, histones isolated from 4-hydroxytamoxifen-
treated MEFs with a PR-Set7flox/; CREERT genotype (Oda
et al., 2009) did not exhibit reactivity with this antibody in western
blots (Figure S2E).
Similar to our observations for H3K27methylation, H4K20me1
nucleosomes contain significant amounts of unmodified or
dimethylated H4K20. For H4K20me1 nucleosomes from ES
cells, H4K20me1 amounts to 75% ± 2%, indicating a roughly
equal proportion of symmetric and asymmetric nucleosomes in
this cell type (Figure 2C). Both MEFs and HeLa cells contain
slightly, but not significantly, higher percentages of symmetric
H4K20me1 nucleosomes (Figure 2C). We thus confirmed the
existence of asymmetric modification for an additional histone
mark on a different histone. Investigation of additional marks
was not tenable at this time, as the corresponding antibodies
tested were insufficiently specific in western blots or failed to
significantly enrich their target sites in IP (data not shown).
A Model for Nucleosomal Asymmetry
Our results indicate that asymmetry of histone modifications
might be a general, hitherto unrecognized feature of nucleo-
somes in vivo. Given the abundance of asymmetric nucleo-
somes, we asked whether a random distribution of modified
histones into nucleosomes could explain asymmetry. To this
end, we calculated the proportion of unmodified, asymmetri-
cally, and symmetrically modified nucleosomes from a
simple binomial distribution. In this model, the distribution ofCell 151, 181–193, September 28, 2012 ª2012 Elsevier Inc. 183
Figure 2. Nucleosomes Are Modified Both Symmetrically and Asymmetrically with H3K27me2/3 and H4K20me1
(A) Example of a mononucleosome affinity purification and specificity controls for an H3K27me2/3-specific antibody.
(B and C) Determination of symmetric and asymmetric populations for H3K27me2/3 (B) and H4K20me1 (C) based on quantitative LC-MS/MS data. Left panels
show data for E14 ES cells, and tables summarize data for the indicated cell types. Results represent average and SEM of at least two independent experiments
based on two different nucleosome preparations per cell type.
See also Figures S1, S2, and S3 and Tables S1 and S2.nucleosome populations is governed by the overall amount of
modified histones (parameter p, Figure S3A). For E14 ES cells,
the overall abundance of H3K27me2/3 was 42% ± 2% (Fig-
ure 2B). A random distribution would result in 48.7% and
17.6% of asymmetrically and symmetrically modified nucleo-
somes, respectively (Figure S3C). Correspondingly, symmetric
nucleosomes would account for only 26% of all modified nucle-
osomes. The disagreement with experimentally observed levels
of symmetry in this and other cases (Figure S3C) argues against
a random distribution of modified histones.
We thus considered an alternative model to explain modifica-
tion asymmetry. In this ‘‘reaction model’’ (Figure S3B), the place-184 Cell 151, 181–193, September 28, 2012 ª2012 Elsevier Inc.ment of PTMs is treated as a two-step reaction process. An initial
recruitment step controls whether a nucleosomewill bemodified
on one histone copy. This step and its efficiency are either gov-
erned by cellular factors or of a stochastic nature. In the next
step, a second modification per nucleosome is placed with a
probability q that determines the degree of symmetry. Assuming
50% efficiency in each step, this model predicts 50% unmodi-
fied nucleosomes and 25% each asymmetrically and symmetri-
cally modified nucleosomes (i.e., 50% symmetry), leading to
37.5% modified tails overall. These values are in reasonable
agreement with the experimental data. With fitting of both
parameters, the model can predict the experimental data with
high accuracy (Figure S3C). We conclude that nucleosomal
asymmetry may be a direct consequence of inherent properties
of the histone-modifying complexes, even thoughmore complex
factors may be involved as well.
Co-Occurrence of H3K27me3 and H3K4me3 within
a Nucleosome
Among several potential implications for nucleosomal structure
and function, asymmetrical modification may increase the range
of attainable histone mark combinations. Of special importance
are the so-called bivalent domains featuring positive H3K4me3
marks and repressive H3K27me3 marks (Fisher and Fisher,
2011; Mikkelsen et al., 2007). Yet these marks have been shown
to hardly ever coexist on individual histone tails (Young et al.,
2009), and the presence of H3K4me3 and H3K36me3 was
reported to inhibit PRC2 (Schmitges et al., 2011). Because the
architecture of nucleosomes at bivalent loci remains elusive,
we attempted to probe the physical co-occurrence of the rele-
vant marks. Moreover, the LC-MS/MS analysis of H3K27me2/3
and H3K4me3 nucleosomes provides direct information on
the overall average modification pattern of nucleosomes from
repressive and active environments, respectively.
For H3K27me2/3 nucleosomes purified from E14 ES cells, we
observed a concomitant occurrence of other repressive marks
such as H3K9me2/3 and H4K20me2, whereas acetylation
was reduced at multiple sites on H3 and H4 (Figure 3A and
Table S2). Complementing these observations, ChIP-seq
studies have shown that di/trimethylation of H3K9 and H3K27
tend to colocalize and that these regions are also largely devoid
of acetylation (Wang et al., 2008). H3K36me2/3, found in actively
transcribed genes, was—although markedly decreased—none-
theless present in H3K27me2/3 nucleosomes (Figure 3A). Similar
observations weremade for MEFs and HeLa cells (Figure 3C and
Table S2). Nucleosomes featuring both H3K27me2/3 and higher
H3K36methylation might arise from domains containing bivalent
or poised genes expressed at low levels or from domains of
a recently described class of expressed genes with mainly
promoter-associated H3K27me3 (Young et al., 2011).
The H3K4me2/3-containing peptides could not be accurately
quantified in our approach due to their low hydrophobicity
and limited interaction with the C18 resin used. However, we
addressed this limitation by probing for H3K27me2/3 on nucleo-
somes affinity purified with an H3K4me3 antibody (Figure S2G).
This antibody significantly enriched its target mark in IP, albeit
not to a population homogeneously modified with H3K4me3.
H3K4me3 mononucleosomes from all cell types analyzed ex-
hibited strong coenrichment with acetylation marks on both H3
and H4 (Figure 3B and Table S2). Moreover, H3K79me2 was
markedly enriched on all H3K4me3 nucleosomes (Figure 3B).
In agreement, genome-wide studies observed colocalization
of H3K4me3 with acetyl marks and H3K79me2 methylation at
regions surrounding transcriptional start sites (Wang et al.,
2008). Conversely, methylation at H3K9 was pronouncedly re-
duced. Interestingly, H3K27me2/3 methylation levels remained
largely unchanged in ES cells (Figure 3B), whereas a reduction
in H3K27me2/3 was observed for H3K4me3 nucleosomes in
MEFs (Figure 3D). These observations demonstrate the exis-
tence of H3K27me3 and H3K4me3 within the same nucleo-somes in ES cells and, to a lesser extent, in more differentiated
cell types such as MEFs. Our data thus provide direct evidence
for the existence of bivalent nucleosomes.
We performed a similar modification analysis for H4K20me1
nucleosomes from ES cells, observing reductions in H3K9me2/3
and slight increases in activating marks such as H3K4me1
and H3K36me2/3 (Figure S4 and Table S2). Of note, the neigh-
boring and potentially antagonizing H4K16ac mark was pre-
sent alongside H4K20me1 and even slightly enriched. Taken
together, the modification pattern of H4K20me1 nucleosomes
is compatible with existence of this mark with H4K16ac in
open chromatin and on active genes, which has been suggested
by ChIP-seq studies (Wang et al., 2008).
H3K4me3 and H3K27me3 Map to Single Nucleosomes
at Bivalent Promoters and Resolve upon Differentiation
As our MS-based data demonstrate that mononucleosomes
containing both H3K4me3 and H3K27me3 exist in vivo, we
aimed to complement these findings with sequential ChIP (re-
ChIP) experiments. In contrast to LC-MS/MS, re-ChIP experi-
ments lack quantitative information on modifications but provide
information on their localization within the genome. To ensure
stable interactions during purification and re-ChIP steps,
mononucleosomes were crosslinked immediately after MNase
digestion. Our monoclonal H3K27me2/3 antibody exhibited
diminished reactivity on crosslinked material (data not shown).
We thus employed a widely used H3K27me3 ChIP antibody
exhibiting minor cross-reactivity with H3K9me3 (Figure S2H)
along with an antibody against H3K4me3 (see Figure S2I for
specificity). In line with the detection of both marks in con-
ventional ChIP experiments, we observed enrichment at the
promoters of the Gata4, Hoxb13, Hoxc5, and Olig1 genes in
re-ChIP for H3K27me3 followed by H3K4me3 (Figure 4A). As
a control, the exclusively H3K4me3-marked promoters of
Pou5f1,Polm, andGapdh did not exhibit enrichment over control
IPs in re-ChIP (Figure 4A). Upon differentiation with retinoic acid,
H3K27me3 is reduced at the Gata4, Hoxb13, and Hoxc5
promoters, which concomitantly show diminished enrichment
in re-ChIP (Figure 4B). In contrast, the Olig1 promoter retains
both H3K27me3 and H3K4me3 under these conditions and
remains positive in re-ChIP (Figure 4B). Taken together, nucleo-
somes carrying both H3K4me3 and H3K27me3 occur at relevant
genomic loci, where they likely function to keep genes in a poised
state in undifferentiated cells. These findings support the preva-
lent view on bivalent domains.
To probe for global changes in asymmetry and co-occurrence
of marks on H3K27me2/3 nucleosomes in the differentiation
process, we affinity purified H3K27me2/3 nucleosomes from
retinoic-acid-treated cells and analyzed their modification status
by LC-MS/MS. H3K27me2/3 nucleosomes from treated cells
exhibited a marginal, nonsignificant decrease in overall sym-
metry (Figure 4C). We observed that those nucleosomes were
further depleted for acetylation at H4 and at some sites on H3,
whereas the repressive H3K9me2/3 and H4K20me3 marks
were elevated compared to the already high levels found on
H3K27me2/3 nucleosomes in untreated cells (Figure 4D). These
findings indicate that active and repressive regions might further
resolve upon differentiation.Cell 151, 181–193, September 28, 2012 ª2012 Elsevier Inc. 185
Figure 3. Co-Occurrence of Histone Marks
with H3K27me2/3 and H3K4me3 in ES,
MEF, and HeLa Cells
(A and B) Modification profile of mono-
nucleosomes prepared from E14 ES cells by
H3K27m2/3 (A) or H3K4me3 (B) antibody-based
affinity purification. Given are fold changes over
input for the indicated sites and modification
states on H3 and H4. For H4 acetylation, abun-
dance of unacetylated to tetra-acetylated species
(H4ac0–4) as well as site-specific acetylation
status (H4Kac5/8/12/16) is shown. Positive values
denote coenrichment, and negative values indi-
cate an inverse correlation with the targeted site.
Results represent average and SEM of at least two
independent experiments each.
(C and D) Modification state of H3K27me2/3 and
H3K4me3 mononucleosomes from ES cells,
MEFs, and HeLa cells. Abundances of methylation
and acetylation states are shown as stacked
columns normalized to 100% for each site. Shown
are averages and SEM of at least two independent
experiments each. ND, not detected.
See also Figures S2 and S4 and Table S2.
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Figure 4. Sequential ChIP Analysis of Bivalent Promoters in ES Cells and Modification State of H3K27me2/3 Nucleosomes in Differentiated
ES Cells
(A and B) ChIP analysis of the indicated promoters with H3K4me3 and H3K27me3 antibodies. (Right) Sequential ChIP with the H3K27me3 followed by H3K4me3
antibody. Assays were performed on untreated E14 cells (A) and E14 ES cells differentiated with retinoic acid (RA) for 6 days (B). The re-ChIP data is given as fold
over IgG control in the second IP. Shown are means and SEM from two independent experiments.
(C) Mononucleosomes were affinity purified from retinoic-acid-treated cells with H3K27me2/3 antibody to assess their symmetry state as described in Figure 2.
Results represent mean and SEM of three independent experiments.
(D) Modification profile of H3K27me2/3 nucleosomes immunopurified from retinoic-acid-differentiated cells. For comparison, the modification state of E14 ES
cells is given. Results represent mean and SEM of three independent experiments.
See also Figures S2H and S2I.
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Figure 5. PRC2 Is Inhibited by Symmetric,
but Not Asymmetric, Presence of H3K4me3
or H3K36me3
(A) Histone methyltransferase assays on oligonu-
cleosome substrates containing H3 with trimethyl-
lysine analogs at the indicated positions either on
both (s) or only one tail (as) per nucleosome. The
asymmetric cases were generated using differ-
entially tagged modified and unmodified histone
H3 and double affinity purification.
(B) Titration of symmetrically and asymmetrically
modified substrates. Panels shown are represen-
tative of three independent assays.
See also Figure S5.PRC2 Is Inhibited by Symmetric, but Not Asymmetric,
Active Methyl Marks
As described above, we observed the co-occurrence of
H3K27me2/3 with H3K4me3 and H3K36me3 within nucleo-
somes (Figure 3 and Table S2), even though occurrence of these
marks within the same histone tail has been shown to be strongly
disfavored (Young et al., 2009; Yuan et al., 2011). To further
investigate the interplay between these marks, we analyzed
the activity of PRC2 on oligonucleosomal substrates carrying
trimethylation marks at defined sites on one or both copies of
H3. The presence of asymmetric H3K27me3 stimulated PRC2
activity toward the unmodified H3 copy (Figure 5A), in line with
our observations that H3K27me3 stimulates PRC2 activity (Mar-
gueron et al., 2009). In agreement with recent studies (Schmitges
et al., 2011; Yuan et al., 2011), PRC2 failed to efficiently meth-
ylate nucleosomes that carry H3K4me3 or H3K36me3 in a sym-
metric fashion (Figures 5A and 5B, top). In contrast, PR-Set7-
mediated methylation of these nucleosomes at H4K20 was not
adversely affected (Figure S5A). Intriguingly, PRC2-mediated
methylation was unaffected if H3K4me3 or H3K36me3 were
present only on one H3 copy (Figures 5A and 5B, bottom). In
conclusion, these findings provide a rationale for the establish-
ment of nucleosomes carrying both activating marks and repres-
sive H3K27me3, as found in bivalent domains and detected in
our analysis.
PRC2 activity on symmetrically modified H3K4me3/
H3K36me3 nucleosomes might be precluded either by dimin-
ished binding of PRC2 or by direct effects on catalysis. We
thus analyzed binding of PRC2 to symmetrically and asymmetri-
cally modified mononucleosomes. PRC2 was found to interact
with both types of nucleosomes without any overt differences
(Figure S5B). It has been shown that the Nurf55 (RbAp46/48 in
mammals) subunit binds the N terminus of H3, and this binding
is abrogated by trimethylation of H3K4 (Schmitges et al.,
2011). Though not affecting overall nucleosome binding, lack188 Cell 151, 181–193, September 28, 2012 ª2012 Elsevier Inc.of H3 binding to Nurf55 was proposed
to be an allosteric signal eliciting inhibi-
tion of the Ezh2 SET domain (Schmitges
et al., 2011). Our data on asymmetric
nucleosomes suggest that this inhibition
requires both tails of H3 to be modified.
In addition, binding of the H3 N terminus
might be required for proper substrate presentation and thus
efficient catalysis.
Mononucleosomes In Vivo Carry H3K27me3
and H3K4me3/H3K36me3 on Separate H3 Tails
To test whether the conformation of nucleosomes in vivo corre-
sponds to the behavior of PRC2 in vitro, we first analyzed the
methylation status of H3K36 in H3K27me2/3 nucleosomes
isolated from ES cells. After tryptic digest, both H3K36 and
H3K27 remain connected within a single tryptic fragment,
H3(27–40), allowing to directly correlate their modification status
on a single histone (Figure 6A). We quantified the relative abun-
dance of H3K36 methylation as a function of the methylation
status at H3K27, distinguishing between H3K27me0/1 and
H3K27me2/3. Strikingly, the bulk of H3K36me2/3 was found
on peptides devoid of H3K27me2/3, indicating their presence
on opposing tails in asymmetric H3K27me2/3 nucleosomes
in vivo (Figure 6B). Upon normalization, it becomes evident
that almost all peptides containing H3K27me2/3 are either
unmodified or monomethylated at H3K36, whereas those
without higher methylation at H3K27 contain all states of
H3K36 methylation, with H3K36me2 and H3K36me3 con-
stituting up to 42% and 5% in ES cells, respectively (Figure 6C).
The exclusion of H3K36me3 from H3K27me2/3 peptides
was consistent between all cell types analyzed, whereas
H3K27me2/3 nucleosomes exhibited slightly less strict ex-
clusion of H3K36me2 in MEF and HeLa cells (Figure 6C). This
observation might be caused by different sets of H3K36me2-
catalyzing enzymes in those cells or by auxiliary PRC2 subunits
that might modulate sensitivity to H3K36me2.
Conducting a similar analysis of H3K4me3 and H3K27me3
occurrence on separate copies of H3 requires the digestion
with Glu-C protease to circumvent the loss of topological in-
formation upon trypsin digest. A drawback of the associated
middle-down MS analysis is a markedly decreased sensitivity
as compared to bottom-up analysis of tryptic fragments,
requiring comparatively large amounts of sample. Despite sig-
nificant scale-up of immunopurifications, we were unable to
obtain sufficient material to perform middle-down analysis of
H3K27me2/3 nucleosomes (data not shown). We therefore
turned to acid-extracted histones to investigate the overall
co-occurrence of H3K4me3 and H3K27me3. As H3K27me2/3
nucleosomes are a subset of all nucleosomes in the cell, the
observations obtained on overall nucleosomes consequently
extend to this subclass as well. We digested the histones with
Glu-C and analyzed the 1–50 peptide from H3.1 by middle-
down LC-MS/MS (Figure 6D). We detected and quantified
peptides that are modified at H3K4 and/or H3K27 with a
custom-made software followed by manual validation. Small
but reliably quantifiable amounts of peptides containing
H3K4me3 along with unmodified, acetylated, or monomethy-
lated H3K27 were detected (Figure 6E). However, we did
not observe any peptides that contain both H3K4me3 and
H3K27me3 (Figure 6E). When performing a similar analysis for
H3K4me2-containing peptides, we observe marginal quantities
of H3K27me3 that make up about 0.3% of all H3K4me2-contain-
ing peptides. Even if one assumes that H3K4me2 may theoreti-
cally substitute for H3K4me3, the observed peptide abundances
are vastly too low to account for the15% bivalent promoters in
ES cells (Mikkelsen et al., 2007). Taken together, these
findings suggest that, in bivalent nucleosomes, H3K4me3 and
H3K27me3 reside on distinct copies of H3 in an asymmetric
fashion in vivo.
DISCUSSION
The relationship between sister histones and the accessible
space of PTM combinations in a nucleosome are key to the
establishment of PTM patterns, themeans by which they convey
information, and their potential inheritance. In this study, we
devised a method to address histone mark symmetry and
provide evidence that sister histones are not necessarily iden-
tical within a nucleosome. This asymmetry in histone modifica-
tions might be a general, hitherto unrecognized, feature of
nucleosomes in vivo.
Experimental Challenges of Probing Nucleosomal
Asymmetry
Addressing the status of histone PTMs on sister histones has so
far been hampered by the absence of adequate techniques. A
recent report showed that H3 can be methylated at H3K27
even if the sister histone within a nucleosome carries a K27A
mutation, which was interpreted as an indication of nucleosome
asymmetry (Chen et al., 2011). We suggest that this observation
reflects the capability of the enzyme to methylate such
a substrate but may not allow conclusions regarding the in vivo
symmetry state. The data presented here were obtained on
native nucleosomes and directly assess symmetry. In the case
of ChIP analyses, co-correlation of different marks at genomic
loci can be assessed in cell populations, but their physical coex-
istence on the same nucleosome cannot be established. An
exception is sequential ChIP performed on native, purified
mononucleosomes. Although these assays have been per-formed, e.g., in the context of bivalent domains (see below),
reports describing their application to the different modification
states of a single site are scarce. Based on such experiments,
H3K4me3 and H3K4me2 have been suggested to co-occur
within nucleosomes (Kouskouti and Talianidis, 2005). However,
results of this and other re-ChIP studies need to be interpreted
cautiously, as insufficient antibody specificity, incomplete re-
moval of the initial antibody, and contamination with oligomeric
nucleosomes can compromise results. The affinity-purification-
based LC-MS/MS analysis described in this study allowed
us to overcome these limitations and enabled us to assess
the symmetry state of nucleosomes in vivo in a quantitative
manner.
Asymmetry of H3K27me2/3 and H4K20me1
We observed asymmetry for two major histone modifications
in several cell lines. Even though antibody specificity issues
precluded analysis of further histone PTMs, we speculate
that asymmetry may not be restricted to H3K27me3 and
H4K20me1. Indeed, our data imply that H3K4me3 and
H3K36me3 are present in asymmetric fashion as well, at least
in the case of bivalent nucleosomes. For both H3K27me2/3
and H4K20me1, differences were small and mostly nonsig-
nificant between cell types and the two marks, indicating that
overall asymmetry may be controlled by characteristics inherent
to the modifying enzymes PRC2 and PR-Set7. Our reaction
model explains the observed proportions of asymmetric nucleo-
somes quantitatively (Figure S3B). A recruitment step coupled
with a first methylation may be followed by a second reaction
with a certain propensity. The nature of the recruitment is irrele-
vant in this model and may in theory be purely stochastic or gov-
erned by specific recruitment mechanisms. It is unclear at
present how the degree of symmetry is controlled and whether
factors exist that modulate symmetric placement of histone
PTMs. The exclusively asymmetric conformation of H3K27me3
at bivalent promoters may represent a special case in which
the presence of another mark imposes asymmetry. Identifying
factors that globally or locally control the degree of symmetry
may enable us to modulate asymmetry in vivo, greatly facilitating
further exploration of its implications.
Nucleosomal Asymmetry May be Key to the
Establishment of Bivalent Domains
Bivalent domains constitute a unique chromatin signature found
atmany gene promoters primarily in ES cells. Their existence has
been demonstrated both by conventional genome-wide ChIP
analysis and re-ChIP studies. Those were mostly performed on
crosslinked, sonicated chromatin fragments (Bernstein et al.,
2006) but also on native MNase-digested chromatin consisting
primarily, but not exclusively, of mononucleosomes (Seenundun
et al., 2010). The use of material containing oligonucleosomes
left the formal possibility that those marks reside on neighboring
nucleosomes. To unambiguously address the existence on
single nucleosomes, the re-ChIP experiments in our study
were carried out on purified mononucleosomes. In agreement
with the interpretation of earlier studies, our data corroborate
that H3K4me3 and H3K27me3 coexist on the same nucleo-
somes at gene promoters. However, re-ChIP cannot distinguishCell 151, 181–193, September 28, 2012 ª2012 Elsevier Inc. 189
Figure 6. Bivalent Nucleosomes Contain H3K27me3 and H3K4me3/H3K36me3 on Opposing Tails In Vivo
(A) Illustration of the experimental design. H3K27me2/3 nucleosomes are immunoaffinity purified and subjected to bottom-up LC-MS/MS analysis. H3K27 and
H3K36 remain on the same peptide, allowing assessment of their interplay on single tails versus nucleosomes.
(B) The relative abundance of peptides detected is grouped according to modification status at H3K27 (open bars, unmodified or me1; red bars, me2, me3). Note
the difference in y axis scale between the panels. Shown are means and SEM of at least three experiments each.
(C) Alternative representation of the data shown in (B). To assess the relative abundance of H3K36 states in the presence or absence of H3K27me2/3, the
percentage of H3K36 states was normalized to the total abundance of peptides with or without H3K27me2/3.
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Figure 7. Model for the Generation of Symmetric and Asymmetric
Nucleosomes by PRC2
Schematic model showing modulation of PRC2 activity by active marks
present on one or both copies of H3 per nucleosome as well as their possible
fates in the transition from ES cells (ESC) to more differentiated lineages (such
as MEFs). Scale of nucleosome symbols in the ESC and MEF panels reflects
their relative abundance.between the different tails of sister histones. Our novel strategy
allowed us not only to provide quantitative information of many
histone PTMs in parallel, but also to distinguish between the
sister histones in a nucleosome for themarks involved in bivalent
domains by employing both bottom-up and middle-down MS
approaches. Our findings provide insight into the architecture
of bivalent nucleosomes and indicate an elegant solution
through placement of the marks on separate tails of H3, allowing
co-occurrence on single nucleosomes.
To explore the mechanistic basis for the generation of such
bivalent nucleosomes observed in vivo, we performed methyl-
transferase assays with PRC2 in vitro on defined, recombinant
nucleosomal substrates with active marks being present either
symmetrically or asymmetrically. Based on our data, we propose
the followingworkingmodel (Figure 7). PRC2 generates predom-
inantly symmetric nucleosomes if activating marks are absent. If
PRC2 encounters asymmetric, but not symmetric, trimethylation
at H3K4 or H3K36, it may place a repressive mark on the oppo-
site tail. This regulation of PRC2 activity provides a rationale for
the establishment of bivalent domains. In the transition from ES
cells to more differentiated cell types, a proportion of these
nucleosomes will be retained at loci that remain poised. Alterna-
tively, they might resolve into nucleosomes carrying either mark
in possibly asymmetric or symmetric fashion. Nucleosomes
carrying only H3K27me3 remain modified upon differentiation
in either symmetric or asymmetric fashion. Our data indicate
that the overall extent of asymmetry does not change signifi-
cantly in, e.g., retinoic acid-induced differentiation. This obser-
vation was obtained on bulk nucleosomes and reflects overall
levels of asymmetry rather than gene-promoter-specific asym-
metry. Changes in symmetry may nonetheless occur at specific
loci, such as resolved bivalent promoters, where symmetry
might be restored, or at loci that become inaccessible to
PRC2, increasing asymmetry. In addition to the active marks
H3K4me3 and H3K36me3, other factors likely control asymme-
try on bulk nucleosome populations. Among them, bound
effector proteins at other sites, for instance HP1 at H3K9, may
diminish accessibility to the second H3 copy, leading to indirect
effects on PRC2 activity.
Potential Implications of Nucleosomal Asymmetry
beyond Bivalent Domains
Exactly how the singular, asymmetric presentation of a histone
mark within a nucleosome affects its function and recognition
in the context of other histone marks is currently unknown. For
example, the presence of a single H3K27me2/3 mark per nucle-
osome might be sufficient to retain a repressed chromatin state.
Conversely, a single H3K4me3 mark might still allow recruitment
of effector proteins such as TFIID, albeit with potentially lower
affinity or altered kinetics. The modification status on the other
tail may be of importance as well, as, e.g., unmodified H4K20(D) Illustration of the middle-down MS approach. Acid-extracted nuclear histon
analyzed.
(E) Abundance of peptides containing H3K4me3 and H3K4me2 plotted as a funct
with custom-made software andmanually validated in some cases. Shown are me
of measurement and misassignment of peptide species by the software.
(F) Alternative representation of the data in (E) with peptide abundances normaliand the repressive H4K20me2 mark may differ in their influence
on H4K20me1. Cell types with overall higher H4K20me2 levels
also exhibited stronger pairing of H4K20me1 with H4K20me2
(Figure 2 and Tables S1 and S2), indicating activity of the
Suv4-20 enzymes as a regulatory element in that case. Dimeric
proteins such as HP1 might experience a greater impact on their
recruitment and mode of action—especially in the context of
chromatin compaction—due to the presence of a single versus
two binding sites per nucleosome. The asymmetric features of
nucleosomes might also influence the emerging concept of
combinatorial recognition of different histonemarks (Ruthenburg
et al., 2011; Taverna et al., 2007; Vermeulen et al., 2007). In
contrast, the stability of a mark at a certain locus is presumably
higher if it is present on both sister histones, rendering it more
refractive to removal by demethylases, for example.
In considering the stability of a given chromatin domain, the
asymmetry between sister histones might significantly impact
their potential inheritance. The semiconservative model postu-
lating segregation of H3-H4 units as dimers relies on the pres-
ence of identical sister histones at the onset of replication. At
loci featuring asymmetric nucleosomes, this condition is not
fulfilled, rendering the general validity of such a mechanism
less tenable. In this regard, a recent report shows that splitting
of H3-H4 tetramers plays only a minor role in HeLa cells duringes were subjected to Glu-C digest, and the resulting H3.1(1–50) peptide was
ion of H3K27 modification state on the same peptides. Peptides were assigned
ans and SEM of three experiments each. The error reflects both technical error
zed to the sum of all H3K4me3/H3K4me2 peptides.
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replication (Xu et al., 2010), and a range of earlier publications
argue against a general splitting of dimers (Annunziato, 2005).
Yet, these studies have been performedmainly with transformed
cells.
Taken together, we provide direct evidence for the existence
of nucleosomes with asymmetric modification states along
with symmetrically modified ones in living cells. As a direct
consequence of the existence of asymmetric nucleosomes,
a semiconservative model of histone mark inheritance might
not generally be applicable. Asymmetric modification, however,
provides efficient means to extend the combinatorial space of
histone marks. We provide evidence that such a mechanism
likely operates in the establishment of bivalency, but other
scenarios are conceivable as well. The admixture of symmetri-
cally and asymmetrically modified nucleosomes might reflect
a widespread regulatory device that impacts chromatin biology
in ways that we have yet to uncover.
EXPERIMENTAL PROCEDURES
Preparation of Mononucleosomes and Immunoaffinity Purification
Mononucleosomes were generated by MNase digestion and sucrose gradient
purification based on established protocols (see Extended Experimental
Procedures). Sucrose gradient fractions containing more than 90% mononu-
cleosomes were pooled and used for subsequent steps. Mononucleosomes
were immunoprecipitated with modification-specific antibodies (5–10 mg per
IP) in IP buffer (50 mM HEPES [pH 7.9], 50 mM NaCl, 50 mM KCl, 5 mM
EDTA, 0.5% NP-40, 0.1% N-lauroyl sarcosine, 5 mM sodium butyrate). After
washing three times with IP buffer, histones were eluted by boiling in SDS
sample buffer and were separated by SDS-PAGE.
Sample Preparation and Quantitative LC-MS/MS Analysis
Procedures for chemical propionylation and tryptic digest were adapted
from previously described solution protocols to in-gel conditions (Garcia
et al., 2007a; Plazas-Mayorca et al., 2009). LC/MS analysis and quantifica-
tion of histone modifications were performed essentially as described
(DiMaggio et al., 2009; Plazas-Mayorca et al., 2009). For detailed bottom-up
and middle-down LC-MS/MS procedures, see Extended Experimental
Procedures.
ChIP and Re-ChIP Assays
ChIP assays on purified, crosslinked mononucleosomes were performed as
described in the Extended Experimental Procedures. Antibodies used for
ChIP were: H3K4me3 (Abcam, ab8580) and H3K27me3 (Millipore, 07-449).
Primers used for quantitative real-time PCR are given in the Extended
Experimental Procedures.
Generation of Modified Histones and Nucleosomes
Recombinant mononucleosomes and chromatin were reconstituted by
salt dialysis as described (Margueron et al., 2009). MLAs were introduced
into recombinant histones as established previously (Margueron et al.,
2009; Simon et al., 2007). Asymmetric octamers containing both unmodi-
fied and modified copies of H3 were obtained by reconstitution from
H3 carrying N-terminal His and Strep tags, respectively, and subse-
quent two-step affinity purification (see details in Extended Experimental
Procedures).
Histone Methyltransferase Assays and PRC2 Interaction Assays
Histone methyltransferase assays and PRC2-nucleosome interaction
assays were performed essentially as described (Margueron et al., 2009).
If not indicated otherwise, 200 ng of purified PRC2 complex or 50 ng of
PR-Set7 were incubated with 1 mg of reconstituted plasmid-based chro-
matin for 1 hr at 30C. See also Extended Experimental Procedures.192 Cell 151, 181–193, September 28, 2012 ª2012 Elsevier Inc.SUPPLEMENTAL INFORMATION
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